Login / Signup

Understanding Australian general practice patients' decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach.

Amy CoeJane GunnZoe AllnuttCatherine Kaylor-Hughes
Published in: BMJ open (2024)
ClinicalTrials.gov NCT05355025; ACTRN12622000567729; ISRCTN11562922; Pre-results.
Keyphrases
  • general practice
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • clinical trial
  • major depressive disorder
  • study protocol
  • phase ii
  • double blind